ASCAT 2022

EHA is joining forces with the British Society of Haematology (BSH) & Annual Academy of Sickle Cell and Thalassaemia Conference (ASCAT) in organizing the 17th Annual Scientific Conference on Sickle Cell and Thalassaemia.

Abstract Submission is open. Click here to submit your abstract

Dates: January 26-28, 2022
Location: Virtual

The Annual Scientific Conference on Sickle Cell and Thalassaemia (ASCAT) focuses on promoting the latest advances in diagnosis, treatment, and emerging fields in hemoglobinopathies. It is an opportunity to interact with peers on the latest advances in clinical care, transition services, and emerging new therapies including updates for curative treatment options.

Abstract submission

Abstract submission is an important part of this meeting. As a participant, you will have the opportunity to submit an abstract for this meeting, and (if accepted) have the possibility to discuss it with the international faculty and your peers.

Please select the most appropriate topic during the abstract & case submission:

  1. Basic and translational,
  2. Novel therapies, gene therapies, bone marrow transplant, and emerging diagnostics,
  3. Clinical and epidemiological studies,
  4. Infection, autoimmunity, nutritional deficiencies,
  5. Ageing and end organ damage,
  6. Health services and outcomes research including psychology.

Accepted abstracts may be presented as an oral presentation or e-poster.

Date Deadline
October 15, 2021 Start abstract & case submission
December 10, 2021 Deadline abstract & case submission
December 20, 2021 Notification of allocation to authors

For any questions regarding the abstract submission process, please contact

Target audience

Consultant Hematologists, Pediatricians, Specialist Nurses, Psychologists, Scientists, Fellows and trainees in all related fields


More details about registration will be published soon.


The full program will be published in the coming weeks.